Our Science

We have built a world-class in-house R&D platform that spans the drug discovery and development process. Our team has discovered and developed our current pipeline of nine drug candidates, including one candidate in registrational trials, two candidates in Phase I/II trials and six candidates at the IND-enabling stage.